SecBot SecBot
Insider Cluster (2 insiders) ·Filed Jun 8, 2026

ADPT

Adaptive Biotechnologies Corp
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago
Insider cluster: 2 insiders, $893K total
Actionable Insight • Neutral

The dollar amount is too small to signal material negative information. Monitor for any upcoming earnings or regulatory filings that could provide context, but no immediate trading action is warranted based on this cluster alone.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
ADPT ▲ +42.05% at T+60d
NEUTRAL call +42.05% · α vs SPY +38.24% · entry $17.36 → $24.66
Entry = T+0 close
Jun 8, 2026
via day close
T+1d
-1.67%
call -1.67% · α -0.09%
$17.07
settled 5mo ago
T+5d
+0.58%
call +0.58% · α -1.84%
$17.46
settled 4mo ago
T+20d
+19.93%
call +19.93% · α +18.48%
$20.82
settled 4mo ago
T+60d
+42.05%
call +42.05% · α +38.24%
$24.66
settled 8w ago

Price Chart

Loading chart...

Executive Summary

Two C-suite insiders at Adaptive Biotechnologies sold a combined $893K in open-market transactions within a 7-day window. The sales represent ~0.03% of the $2.7B market cap, which is trivial in proportion. No insider buying occurred, and the derivative exercises by the Chief People Officer were non-cash events with no economic signal.

Key Financial Metrics

Direction
selling
Total Value
$893.0K
Insiders
2

Key Facts

  • Chief People Officer sold 39,741 shares at $17.49 for $695K on June 4, 2026
  • Chief Commercial Officer (MRD) sold 11,000 shares at $18.00 for $198K on June 4, 2026
  • Total open-market sales: $893K, representing ~0.03% of market cap
  • No insider purchases in the cluster; all derivative exercises were non-cash
  • Sales are below the 0.1% of market cap threshold for materiality

Financial Impact

Total insider sales of $893K, trivial relative to $2.7B market cap

insider holdings

Risk Factors

  • Insider sales could be liquidity-driven or part of pre-arranged 10b5-1 plans
  • No buying activity to offset the selling signal

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
86% bullish (14 analysts)

Investment Themes

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-ADPT-1780964992298
28 reports for ADPT
Performance horizon
45% Hit rate @ T+20 5 of 11 directional calls Went positive at some point 7 of 11 best @ T+60▲ +56.41%May 5, 2026
Filters
Rows
Reports for ADPT — sortable, filterable
TypeNow
Oct 6, 2026
20d ago
144
NEUTRAL ★ 2/10
$26.28awaiting T+20—$26.27 (−0.04%)
Oct 5, 2026
20d ago
Insider Cluster
NEUTRAL ★ 3/10
$26.90awaiting T+20—$26.27 (−2.34%)
Sep 25, 2026
4w ago
Press Release
BULLISH ★ 6/10
$29.43 $25.51▼ −13.32%▼ −11.84%$26.27 (−10.74%)
Sep 18, 2026
5w ago
Insider Cluster
BEARISH ★ 5/10
$27.86 $23.95▲ +14.03%▲ +13.13%$26.27 (+5.71%)
Aug 20, 2026
9w ago
Insider Cluster
NEUTRAL ★ 4/10
$25.99 $27.86▲ +7.20%▲ +7.72%$26.27 (+1.08%)
Aug 19, 2026
9w ago
Insider Cluster
BEARISH ★ 5/10
$25.44 $28.55▼ −12.22%▼ −12.22%$26.27 (−3.26%)
Aug 18, 2026
9w ago
144
NEUTRAL ★ 3/10
$25.49 $26.68▲ +4.67%▲ +6.19%$26.27 (+3.06%)
Aug 17, 2026
10w ago
144
BEARISH ★ 4/10
$24.56 $27.67▼ −12.66%▼ −13.97%$26.27 (−6.96%)
Jul 29, 2026
12w ago
Institutional Cluster
BEARISH ★ 4/10
$24.18 $26.44▼ −9.35%▼ −5.38%$26.27 (−8.64%)
Jul 23, 2026
13w ago
Insider Cluster
NEUTRAL ★ 4/10
$22.27 $25.99▲ +16.70%▲ +13.08%$26.27 (+17.96%)
Showing 10 of 28

US Market Status

Market Closed — Opens Tue (< 1m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 8, 2026